Sign In
Buy CLDX
$33.41
+0.98 (+3.02%)
At Close: Jun 22, 2026
Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates
07:34pm, Thursday, 05'th May 2022
Celldex (CLDX) delivered earnings and revenue surprises of -6.52% and 76.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amryt Pharma PLC Sponsored ADR (AMYT) Reports Q1 Loss, Tops Revenue Estimates
12:25pm, Wednesday, 04'th May 2022 Zacks Investment Research
Amryt Pharma PLC Sponsored ADR (AMYT) delivered earnings and revenue surprises of 0% and 2.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the sto
Celldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation
06:12am, Tuesday, 01'st Mar 2022 Seeking Alpha
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript
01:57am, Tuesday, 01'st Mar 2022 Seeking Alpha
Celldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84M (NASDAQ:CLDX)
09:02pm, Monday, 28'th Feb 2022 Seeking Alpha
Celldex press release (NASDAQ:CLDX): Q4 GAAP EPS of -$0.43 misses by $0.02.Revenue of $0.33M (-91.3% Y/Y) misses by $0.84M.
Celldex Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
09:01pm, Monday, 28'th Feb 2022 GlobeNewswire Inc.
HAMPTON, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the fourth quarter and year ended December 31, 2021 and provided a corp
Celldex Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
09:01pm, Monday, 28'th Feb 2022 GlobeNewswire
HAMPTON, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript
08:57pm, Monday, 28'th Feb 2022
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript
Celldex Q4 2021 Earnings Preview (NASDAQ:CLDX)
10:35pm, Sunday, 27'th Feb 2022 Seeking Alpha
Celldex (NASDAQ:CLDX) is scheduled to announce Q4 earnings results on Monday, February 28th, after market close.The consensus EPS Estimate is -$0.36 and the consensus Revenue Estimate…
Celldex to Host Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights Conference Call
09:01pm, Tuesday, 22'nd Feb 2022 GlobeNewswire Inc.
HAMPTON, N.J., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced it will host a conference call and webcast on Monday, February 28, 2022 at 4:30 p.m. ET to d
Celldex to Host Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights Conference Call
09:01pm, Tuesday, 22'nd Feb 2022 GlobeNewswire
HAMPTON, N.J., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced it will host a conference call and webcast on Monday, February 28, 2022 at 4:30 p.m. ET to discuss its fourth quarter and full year 2021 financial results and corporate highlights.
Celldex to Host Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights Conference Call
04:01pm, Tuesday, 22'nd Feb 2022
HAMPTON, N.J., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced it will host a conference call and webcast on Monday, February 28, 2022 at 4:30 p.m. ET to dis
Celldex Therapeutics (CLDX) Investor Presentation - Slideshow
06:32pm, Thursday, 17'th Feb 2022 Seeking Alpha
Celldex to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09:05pm, Thursday, 10'th Feb 2022 GlobeNewswire Inc.
HAMPTON, N.J., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a virtual fireside chat at the 11th Annual SVB Le
Celldex to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09:05pm, Thursday, 10'th Feb 2022 GlobeNewswire
HAMPTON, N.J., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a virtual fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022 at 1:00 p.m. ET.
